Johnson & Johnson PFA Launch Puts VARIPULSE Pro And Valuation In Focus [Yahoo! Finance]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Yahoo! Finance
Johnson & Johnson (NYSE:JNJ) has launched its VARIPULSE Pro pulsed field ablation system in Europe following CE Mark approval. The system is aimed at faster, potentially more efficient cardiac ablation procedures, with real world evidence now being collected through a multi center study. Initial clinical use is underway, supported by live demonstrations and plans to share interim results at major medical conferences. For Johnson & Johnson, the VARIPULSE Pro rollout adds another device to its MedTech portfolio at a time when electrophysiology and minimally invasive cardiac care remain areas of active product development. The PFA approach is designed to target heart tissue with more precision than traditional thermal ablation, which is a key focus for clinicians looking to refine atrial fibrillation treatment workflows. For investors watching NYSE:JNJ, this launch highlights how the company is leaning into technology driven procedure efficiency and hospital throughput themes. T
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Johnson & Johnson (JNJ) had its price target raised by Morgan Stanley from $262.00 to $267.00. They now have an "overweight" rating on the stock.MarketBeat
- Johnson & Johnson Showcases New Clinical Data for TECNIS PureSee IOL at ASCRS 2026 Demonstrating Excellent Contrast Sensitivity and Extended Range of VisionBusiness Wire
- Johnson & Johnson (JNJ) Increases Yet Falls Behind Market: What Investors Need to Know [Yahoo! Finance]Yahoo! Finance
- How Raw Sugar Living's CEO Is Fighting Inflation In The Beauty Aisle [Forbes]Forbes
- Johnson & Johnson (JNJ) is now covered by TD Cowen. They set a "buy" rating and a $250.00 price target on the stock.MarketBeat
JNJ
Earnings
- 1/21/26 - Beat
JNJ
Sec Filings
- 3/26/26 - Form SCHEDULE
- 3/18/26 - Form 13F-HR/A
- 3/18/26 - Form 13F-HR/A
- JNJ's page on the SEC website